View in EDS

Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.

Saved in:
Bibliographic Details
Title: Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
Authors: Greter H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Ivol S; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Oriol Mathieu V; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Erismann S; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Prytherch H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Steinmann P; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: Peter.steinmann@swisstph.ch.
Source: Vaccine [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 580-587. Date of Electronic Publication: 2020 Dec 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33342636
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Greter+H%22">Greter H</searchLink>; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ivol+S%22">Ivol S</searchLink>; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Oriol+Mathieu+V%22">Oriol Mathieu V</searchLink>; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Erismann+S%22">Erismann S</searchLink>; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Prytherch+H%22">Prytherch H</searchLink>; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Steinmann+P%22">Steinmann P</searchLink>; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: Peter.steinmann@swisstph.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 580-587. <i>Date of Electronic Publication: </i>2020 Dec 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33342636
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2020.12.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 580
    Titles:
      – TitleFull: Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Greter H
      – PersonEntity:
          Name:
            NameFull: Ivol S
      – PersonEntity:
          Name:
            NameFull: Oriol Mathieu V
      – PersonEntity:
          Name:
            NameFull: Erismann S
      – PersonEntity:
          Name:
            NameFull: Prytherch H
      – PersonEntity:
          Name:
            NameFull: Steinmann P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 01
              Text: 2021 Jan 15
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1